S 3188 · 119th Congress · Science, Technology, Communications

Biomanufacturing Excellence Act of 2025

Introduced 2025-11-18· Sponsored by Sen. Coons, Christopher A. [D-DE]· Senate

Bill Progress

Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Read twice and referred to the Committee on Commerce, Science, and Transportation.(2025-11-18)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 3188 Introduced in Senate (IS)] <DOC> 119th CONGRESS 1st Session S. 3188 To establish a Biopharmaceutical Center of Excellence, and for other purposes. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES November 18, 2025 Mr. Coons (for himself and Mr. Budd) introduced the following bill; which was read twice and referred to the Committee on Commerce, Science, and Transportation _______________________________________________________________________ A BILL To establish a Biopharmaceutical Center of Excellence, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Biomanufacturing Excellence Act of 2025''. SEC. 2. FINDINGS; SENSE OF CONGRESS. (a) Findings.--Congress finds the following: (1) Biotechnology is the designing and engineering of biological systems. Biotechnology allows scientists to grow everything from medicines to crops to materials, enabling ``biology by design''. (2) Biotechnology holds th…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (3)

1 Democrat2 Republicans